Form 4 for TWST Twist Bioscience Corp
Accepted 2023-05-23 00:00:00 ET · period of report 2023-05-19 · accession 0001214659-23-007733 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-23 | 2023-05-19 | TWST | Finn Patrick John | Pres, COO | F - Tax | $13.03 | -1,027 | 95.9K | -1% | -$13.4K |
| D | 2023-05-23 | 2020-09-01 | TWST | Finn Patrick John | Pres, COO | A - Grant | $0.00 | +23.4K | 23.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-19 | F | D | 1,027 | $13.03 | 95,946 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
| 2 | Derivative | Employee Stock Option (right to buy) | 2020-09-01 | A | A | 23,355 | $0.00 | 23,355 | D | $67.85 · 2022-12-19 to 2030-08-31 | 23,355 Common Stock | (F2) Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria. |